Premium
Changes in regulatory molecules for lymphangiogenesis in intestinal lymphangiectasia with enteric protein loss
Author(s) -
Hokari Ryota,
Kitagawa Noritake,
Watanabe Chikako,
Komoto Shunsuke,
Kurihara Chie,
Okada Yoshikiyo,
Kawaguchi Atsushi,
Nagao Shigeaki,
Hibi Toshifumi,
Miura Soichiro
Publication year - 2008
Publication title -
journal of gastroenterology and hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.214
H-Index - 130
eISSN - 1440-1746
pISSN - 0815-9319
DOI - 10.1111/j.1440-1746.2007.05225.x
Subject(s) - medicine , lymphangiogenesis , lymphangiectasia , lymphedema , gastroenterology , pathology , lymphatic system , cancer , metastasis , breast cancer
Background and Aim: Vascular endothelial growth factor receptor 3 (VEGFR3) and LYVE‐1 are specifically expressed in the endothelium of the lymphatic systems. VEGF‐C, D, FOXC2, Prox 1, and SOX18 are known to play central roles in lymphatic development. We investigated the expression of regulatory molecules for lymphangiogenesis in the duodenal mucosa of idiopathic intestinal lymphangiectasia. Methods: Biopsy samples were obtained from duodenal biopsies in patients with intestinal lymphangiectasia complicated with protein‐losing from white spot lesions in which lymphangiectasia was histologically confirmed. Immunohistochemical analysis for VEGFR3 and LYVE‐1 was performed. mRNA expression of VEGF‐C, VEGF‐D, VEGFR3, and transcription factors was determined by the quantitative reverse transcription–polymerase chain reaction method. Results: In the control mucosa, VEGFR3 was weakly expressed on the central lymphatic vessels in the lamina propria and LYVE‐1 was expressed mainly on the lymphatic vessels in the submucosa. In intestinal lymphangiectasia, VEGFR3 and LYVE‐1 expression levels were increased on the mucosal surface corresponding to widely dilated lymphatic vessels, while they were decreased in the deeper mucosa. mRNA expression study showed a significant increase in the expression level of VEGFR3 in lymphangiectasia, but the expression of VEGF‐C and ‐D mRNA was significantly suppressed compared with that in controls despite the presence of lymphangiectasia. The mRNA expression levels of FOXC2 and SOX18 were also decreased, whereas Prox 1 was not altered. Conclusions: There is an altered expression of regulatory molecules for lymphangiogenesis in the duodenal mucosa in these patients.